title: Successful treatment of Type B insulin resistance in a patient with otherwise quiescent systemic lupus erythematosus.
authors.forename: A P
authors.initials: AP
authors.lastname: Coll
authors.forename: D
authors.initials: D
authors.lastname: Morganstein
authors.forename: D
authors.initials: D
authors.lastname: Jayne
authors.forename: M A
authors.initials: MA
authors.lastname: Soos
authors.forename: S
authors.initials: S
authors.lastname: O'Rahilly
authors.forename: J
authors.initials: J
authors.lastname: Burke
mesh_terms: D000328:Adult; D048909:Diabetes Complications; D005260:Female; D005938:Glucocorticoids / Q000008:administration & dosage; D006801:Humans; D006943:Hyperglycemia / Q000188:drug therapy*; D007004:Hypoglycemic Agents / Q000627:therapeutic use; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D007328:Insulin / Q000627:therapeutic use; D007333:Insulin Resistance; D008180:Lupus Erythematosus, Systemic / Q000150:complications*; D010956:Plasmapheresis / Q000379:methods*; D011239:Prednisolone / Q000008:administration & dosage; D016896:Treatment Outcome
chemical_list: D005938:Glucocorticoids; D007004:Hypoglycemic Agents; D007166:Immunosuppressive Agents; D007328:Insulin; D011239:Prednisolone